EP3612234
COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.4.2018EP published:
13.3.2024EP application number:
18719162.2
EPO information:
European Patent Register
Max expiry date:
19.4.2038
Title in English:
COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATELanguage of the patent:
English
Timeline
Today
20.4.2018EP application
13.3.2024EP Publication
Owner
Name:
ADC Therapeutics SAAddress:
Biopôle Route de la Corniche 3B, 1066 Epalinges, CH
Name:
Medimmune LimitedAddress:
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB
Inventor
Name:
VAN BERKEL, Patricius Hendrikus CornelisAddress:
1066 Epalinges, CH
Name:
WUERTHNER, JensAddress:
1066 Epalinges, CH
Name:
HARTLEY, JohnAddress:
London Greater London WC1E 6BT, GB
Name:
ZAMMARCHI, FrancescaAddress:
1066 Epalinges, CH
Priority
Number:
201706231Date:
20.4.2017Country:
GB
Number:
201706230Date:
20.4.2017Country:
GB
Number:
201706229Date:
20.4.2017Country:
GB
Number:
201706228Date:
20.4.2017Country:
GB
Number:
201706227Date:
20.4.2017Country:
GB
Number:
201706226Date:
20.4.2017Country:
GB
Number:
201706225Date:
20.4.2017Country:
GB
Number:
201706224Date:
20.4.2017Country:
GB
Number:
201706223Date:
20.4.2017Country:
GB
Classification
Categories:
A61K 47/68, A61K 31/7068, A61K 31/706, A61K 31/502, A61K 45/06, A61P 35/00